Ci Chu is Chief Discovery Officer at Xaira Therapeutics, an AI-native biotechnology startup. He outlines the company's core technological architecture.
“There are three main AI platforms that we're building here. The first one is Protein Design, work that spun out of our co-founder Dr. David Baker's group from UW. A lot of the current generation of protein designers are here in the company. So there, the thinking is to use advanced AI technology to develop molecules against previously undruggable targets. The second AI platform, I guess we'll spend a lot of time talking about today is the one that Bill and I have been working on for quite some time and just released the preprint on. That's the Virtual Cell or Foundation Model of Biology work. There, the hope is to build an AI model To predict biology, exactly like you said, and predict what genes and drug molecules will affect cell biology. And the third piece, which we're beginning to build now, is patient representation models. And the goal there is to have AI models that can understand which patients will respond to which therapeutics.”
quote is from the automated transcript, cleaned for reading:
filler sounds and stutters are removed, nothing is rephrased. names can be misheard
(the analysis reads context, assessments check outside sources). how →
More from Ci Chu
AssertionSupported
Chu: Descriptive Models Fail to Beat Linear Baselines on Causal Biology
“Models that are trained on descriptive data do not yet outperform linear models on causal tasks, perturbational tasks, what we call counterfactual tasks.”
Ci ChuJul 21, 2026▶ 21:47🔬Causal Models Need Causal Data - Xaira’s X-Cell model (Bo Wang & Ci Chu)
Insight
Chu: Observational Profiling Data Cannot Learn Biological Causality
“Fundamentally, we believe our provisional data are underpowered to learn causality, truly.”
Ci ChuJul 21, 2026▶ 22:45🔬Causal Models Need Causal Data - Xaira’s X-Cell model (Bo Wang & Ci Chu)
AssertionSupported
Chu: X-Cell Predicts Perturbation Effects In Unseen Activated T Cells
“Critically, Excel has not seen active cell T cells. And it's able to make accurate prediction, not only on the known biology, the TCR complex, predicting their effect accurately, that these are going to inactive the T cells, which It's exactly what we would ex…”
Ci ChuJul 21, 2026▶ 57:35🔬Causal Models Need Causal Data - Xaira’s X-Cell model (Bo Wang & Ci Chu)
AssertionSupported
Chu: Xaira is first to combine seven genome-wide Perturb-seq campaigns
“It is the first time that someone can put together not just one perturbseek, but seven genome-wide perturbseek campaigns together.”
Ci ChuJul 21, 2026▶ 1:05:59🔬Causal Models Need Causal Data - Xaira’s X-Cell model (Bo Wang & Ci Chu)
Insight
Chu: Academia drives accidental discovery while industry excels at scaling data
“These innovations take so long and the discovery process can be so accidental, right, that It's perhaps not ideal for pure industry to take on, but once they show early promise, scaling them, and robustifying them, and generating data that's not only massive, …”
Ci ChuJul 21, 2026▶ 1:17:57🔬Causal Models Need Causal Data - Xaira’s X-Cell model (Bo Wang & Ci Chu)
Insight
Chu: Virtual cell models lag due to high-quality data limitations
“In the other domains, such as clinical model prediction, such as virtual cell, we are nowhere near the same kind of massive data that are high quality, and I think it's mainly a data limitation issue.”
Ci ChuJul 21, 2026▶ 9:46🔬Causal Models Need Causal Data - Xaira’s X-Cell model (Bo Wang & Ci Chu)
Made with StarZero
Turn any episode into a week of clips.
This entire site, over 200 episodes transcribed, diarized, checked and made playable,
runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the
moments worth sharing, cuts them, captions them, and reframes them for every feed.
We use essential cookies to make the site work. With your permission we
also use analytics cookies (Google Analytics and Mixpanel) to understand
usage and improve StarZero. See our Cookie Policy.